COLUMBIA LABORATORIES TO PRESENT AT THE ROTH 21ST ANNUAL OC GROWTH STOCK CONFERENCE ON FEBRUARY 18, 2009
Printer-friendly version
PDF version
LIVINGSTON, NJ— February 9, 2009—Columbia Laboratories, Inc. (Nasdaq: CBRX) announced today that Robert S. Mills, president and chief executive officer of Columbia Laboratories, Inc. will present at the upcoming ROTH 21st Annual OC Growth Stock Conference.
|
style="width: 1.2in; height: 13.95pt; border: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
Date:
|
style="width: 315.0pt; height: 13.95pt; border-left: medium none; border-right: 1.0pt solid white; border-top: 1.0pt solid white; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
Wednesday, February 18, 2009 |
|
style="width: 1.2in; height: 13.85pt; border-left: 1.0pt solid white; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
Time:
|
style="width: 315.0pt; height: 13.85pt; border-left: medium none; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
1:00 p.m. PT |
|
style="width: 1.2in; height: 13.85pt; border-left: 1.0pt solid white; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
Venue:
|
style="width: 315.0pt; height: 13.85pt; border-left: medium none; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
The Ritz-Carlton Laguna Niguel |
|
style="width: 1.2in; height: 13.85pt; border-left: 1.0pt solid white; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
Live webcast:
|
style="width: 315.0pt; height: 13.85pt; border-left: medium none; border-right: 1.0pt solid white; border-top: medium none; border-bottom: 1.0pt solid white; padding-left: 5.4pt; padding-right: 5.4pt; padding-top: 0in; padding-bottom: 0in">
href="http://www.cbrxir.com/events.htm">www.cbrxir.com
|
The webcast of the presentation will be archived for 90 days on Columbia Laboratories’ investor website,www.cbrxir.com,under "Events."
About Columbia Laboratories
Columbia Laboratories, Inc. is a specialty pharmaceutical company focused on developing and marketing products for the reproductive healthcare and endocrinology markets using its novel bioadhesive drug delivery technology. For more information, please visit www.columbialabs.com.
###
|
Company Contact:
|
Investor and Media Contact:
|
|
James A. Meer |
Melody A. Carey, |
|
Senior Vice President,CFO & Treasurer |
Co-President, Rx Communications, LLC |
|
(973) 486-8860 |
(917) 322-2571 |
Copy this html code to your website/blog and link to this press release.
More User Press Releases
- COLUMBIA LABORATORIES ANNOUNCES LEADERSHIP CHANGES
- COLUMBIA LABORATORIES RECEIVES NASDAQ NOTICE OF NON-
- COLUMBIA LABORATORIES COMMENTS ON STOCK ACTIVITY
- COLUMBIA LABORATORIES CLOSES REGISTERED DIRECT COMMON STOCK AND WARRANT OFFERING
- COLUMBIA LABORATORIES TO DISCUSSFOURTH QUARTER AND YEAR-END 2008 FINANCIAL RESULTS ON MARCH 5, 2009 CONFERENCE CALL
- COLUMBIA LABORATORIES TO DISCUSS THIRD QUARTER 2009 FINANCIAL RESULTS
- COLUMBIA LABORATORIES TO ADDRESS STRATEGIC ISSUES
- LAWRENCE GYENES APPOINTED CHIEF FINANCIAL
- Columbia Laboratories Raises $750,000 through Sale of Common Stock
- COLUMBIA LABORATORIES TO PRESENT AT THE COWEN AND
Facebook
Twitter
del.icio.us
LinkedIn
Digg
StumbleUpon
Forward
Google
Favorite
Favorite on Technorati